RetractedArticleOncoTargets and therapy2018

miR-19b serves as a prognostic biomarker of breast cancer and promotes tumor progression through PI3K/AKT signaling pathway.

Chuansheng Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.